
VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austeo)
3/11/2026
0:00
17:19
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).
References:
https://pubmed.ncbi.nlm.nih.gov/41626799/
https://www.ncbi.nlm.nih.gov/books/NBK548187/
https://pubmed.ncbi.nlm.nih.gov/41626799/
More episodes from "PsychRounds: The Psychiatry Podcast"



Don't miss an episode of “PsychRounds: The Psychiatry Podcast” and subscribe to it in the GetPodcast app.








